Bayer Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Realignment into two separate divisions - Self-Testing Systems and Professional Testing Systems - will take effect June 1 to account for "different market and strategic business needs," firm explains April 23. The Self-Testing division includes the Ascensia line of blood glucose monitoring equipment. Professional Testing will market the firm's laboratory-, hospital- and physician-use products, such as the Advia automated diagnostic processing system and Clinitek Atlas urine chemistry analyzer. Bayer Diagnostics, itself a unit of Bayer HealthCare, had sales of $2.1 bil. in 2003...